Company intelligence
INNOVOTEX INC.
Selective Tumor Retention. Predictable Outcomes.
Biotechnology Research
Austin, US
5 employees
1 public signals
About INNOVOTEX INC.
INNOVOTEX is a pharmaceutical company advancing Macrocycle Drug Conjugates (MDCs), a novel therapeutic platform designed to improve tumor localization, retention, and intracellular delivery. Its lead candidate, NOVO-111, is being developed to address persistent limitations in oncology through enhanced therapeutic exposure and durability.
Verified activity
Signals from INNOVOTEX INC.
1 published signal